Research Interests
Juvenile myositis, lupus, and localized scleroderma. Patient-reported outcomes, mental health, stress, adverse childhood experiences, cardiovascular health, psychometrics, and qualitative/mixed methods research. Novel therapies and clinical trials for pediatric rheumatic diseases.
Selected Grants
Pediatrics Juvenile Myositis program support
ResearchCo Investigator · Awarded by Cure JM Foundation · 2019 - 2025Supporting Development of Interventions to Reduce Stress and Promote Cardiovascular Health in Juvenile Lupus and Dermatomyositis
ResearchPrincipal Investigator · Awarded by Rheumatology Research Foundation · 2024 - 2025Psychological Stress and Cardiovascular Health in Juvenile Lupus and Dermatomyositis
ResearchPrincipal Investigator · Awarded by Rheumatology Research Foundation · 2021 - 2025Facilitating international, multi-disciplinary collaboration in pediatric localized scleroderma research: International validation of outcome measures
ResearchCo Investigator · Awarded by Childhood Arthritis & Rheumatology Research Alliance, Inc. · 2021 - 2024CARRA Early Investigator Chair Support
ResearchPrincipal Investigator · Awarded by Childhood Arthritis & Rheumatology Research Alliance, Inc. · 2020 - 2023Vamorolone in Juvenile Autoimmune Myositis
Clinical TrialPrincipal Investigator · Awarded by Cure JM Foundation · 2020 - 2022Mental Health Screening in Juvenile Myositis: Pilot and Feasibility Study
ResearchPrincipal Investigator · Awarded by Childhood Arthritis & Rheumatology Research Alliance, Inc. · 2019 - 2022Adverse Childhood Experiences in Juvenile Idiopathic Arthritis
ResearchPrincipal Investigator · Awarded by Albert Einstein College of Medicine · 2019 - 2021CARRA Early Investigator Vice Chair Support
ResearchPrincipal Investigator · Awarded by Childhood Arthritis & Rheumatology Research Alliance, Inc. · 2019 - 2021External Relationships
- Childhood Arthritis and Rheumatology Research Alliance
- Rheumatology Research Foundation
- University of Chicago
- cabaletta Bio, Inc
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.